BTRX-246040 Administered Once Daily to Patients With Major Depressive Disorder
Clinical trial NCT03193398 · COMPLETED
Trial details
- NCT number
- NCT03193398
- Sponsor
- BlackThorn Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-12
- Primary completion
- 2018-11-12
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.